{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:44:24Z","timestamp":1786981464108,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10902-8","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T15:51:44Z","timestamp":1754581904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Connexin 43 inhibitors reduce cell viability in glioblastoma and astrocyte co-culture systems"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0058-239X","authenticated-orcid":false,"given":"Ali","family":"Genc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7999-7680","authenticated-orcid":false,"given":"Berfin","family":"Uzunkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-651X","authenticated-orcid":false,"given":"Gizem Inetas","family":"Yengin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0776-1238","authenticated-orcid":false,"given":"Didem","family":"Tecimel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5644-5725","authenticated-orcid":false,"given":"Altay Burak","family":"Dalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7562-6604","authenticated-orcid":false,"given":"Omer Faruk","family":"Bayrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"issue":"5","key":"10902_CR1","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.3390\/ijms25053040","volume":"25","author":"Z Lan","year":"2024","unstructured":"Lan Z, Li X, Zhang X, Glioblastoma (2024) An update in pathology, molecular mechanisms and biomarkers. Int J Mol Sci 25(5):3040","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10902_CR2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.5306\/wjco.v15.i2.178","volume":"15","author":"AA Mohamed","year":"2024","unstructured":"Mohamed AA, Alshaibi R, Faragalla S, Mohamed Y, Lucke-Wold B (2024) Updates on management of gliomas in the molecular age. World J Clin Oncol 15(2):178\u2013194","journal-title":"World J Clin Oncol"},{"issue":"14","key":"10902_CR3","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1080\/14656566.2022.2125302","volume":"23","author":"E Aquilanti","year":"2022","unstructured":"Aquilanti E, Wen PY (2022) Current therapeutic options for glioblastoma and future perspectives. Expert Opin Pharmacother 23(14):1629\u20131640","journal-title":"Expert Opin Pharmacother"},{"issue":"11","key":"10902_CR4","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3390\/brainsci13111536","volume":"13","author":"RS Angom","year":"2023","unstructured":"Angom RS, Nakka NMR, Bhattacharya S (2023) Advances in glioblastoma therapy: an update on current approaches. Brain Sci 13(11):1536","journal-title":"Brain Sci"},{"issue":"7","key":"10902_CR5","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.3390\/ijms22073301","volume":"22","author":"A Virtuoso","year":"2021","unstructured":"Virtuoso A, Giovannoni R, De Luca C, Gargano F, Cerasuolo M, Maggio N et al (2021) The glioblastoma microenvironment: morphology, metabolism, and molecular signature of glial dynamics to discover metabolic rewiring sequence. Int J Mol Sci 22(7):3301","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10902_CR6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/glia.23520","volume":"67","author":"M Brandao","year":"2019","unstructured":"Brandao M, Simon T, Critchley G, Giamas G (2019) Astrocytes, the rising stars of the glioblastoma microenvironment. Glia 67(5):779\u2013790","journal-title":"Glia"},{"issue":"2","key":"10902_CR7","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/glia.23718","volume":"68","author":"A Mega","year":"2020","unstructured":"Mega A, Hartmark Nilsen M, Leiss LW, Tobin NP, Miletic H, Sleire L et al (2020) Astrocytes enhance glioblastoma growth. Glia 68(2):316\u2013327","journal-title":"Glia"},{"issue":"23","key":"10902_CR8","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1038\/s41388-019-0741-6","volume":"38","author":"T Aasen","year":"2019","unstructured":"Aasen T, Leithe E, Graham SV, Kameritsch P, May\u00e1n MD, Mesnil M et al (2019) Connexins in cancer: bridging the gap to the clinic. Oncogene 38(23):4429\u20134451","journal-title":"Oncogene"},{"key":"10902_CR9","doi-asserted-by":"publisher","first-page":"110125","DOI":"10.1016\/j.biopha.2020.110125","volume":"127","author":"X Wang","year":"2020","unstructured":"Wang X, Feng L, Xin M, Hao Y, Wang X, Shang P et al (2020) Mechanisms underlying astrocytic connexin-43 autophagy degradation during cerebral ischemia injury and the effect on neuroinflammation and cell apoptosis. Biomed Pharmacother 127:110125","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10902_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41389-022-00378-7","volume":"11","author":"KJ Pridham","year":"2022","unstructured":"Pridham KJ, Shah F, Hutchings KR, Sheng KL, Guo S, Liu M et al (2022) Connexin 43 confers chemoresistance through activating PI3K. Oncogenesis 11(1):1\u201311","journal-title":"Oncogenesis"},{"key":"10902_CR11","doi-asserted-by":"crossref","unstructured":"Yang ZJ, Zhang LL, Bi QC, Gan LJ, Wei MJ, Hong T et al (2021) Exosomal connexin 43 regulates the resistance of glioma cells to Temozolomide. Oncol Rep.;45(4)","DOI":"10.3892\/or.2021.7995"},{"issue":"1","key":"10902_CR12","first-page":"295","volume":"52","author":"L Wang","year":"2018","unstructured":"Wang L, Peng Y, Peng J, Shao M, Ma L, Zhu Z et al (2018) Tramadol attenuates the sensitivity of glioblastoma to Temozolomide through the suppression of Cx43\u2013mediated gap junction intercellular communication. Int J Oncol 52(1):295\u2013304","journal-title":"Int J Oncol"},{"issue":"2","key":"10902_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1158\/1541-7786.MCR-21-0199","volume":"20","author":"S McCutcheon","year":"2022","unstructured":"McCutcheon S, Spray DC (2022) Glioblastoma-Astrocyte connexin 43 gap junctions promote tumor invasion. Mol Cancer Res 20(2):319\u2013331","journal-title":"Mol Cancer Res"},{"issue":"1","key":"10902_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12929-019-0497-x","volume":"26","author":"JI Wu","year":"2019","unstructured":"Wu JI, Wang LH (2019) Emerging roles of gap junction proteins connexins in cancer metastasis, chemoresistance and clinical application. J Biomed Sci 26(1):8","journal-title":"J Biomed Sci"},{"issue":"5","key":"10902_CR15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.2174\/0929867323666160112122256","volume":"23","author":"A Roohbakhsh","year":"2016","unstructured":"Roohbakhsh A, Iranshahy M, Iranshahi M (2016) Glycyrrhetinic acid and its derivatives: Anti-Cancer and cancer chemopreventive properties, mechanisms of action and Structure- cytotoxic activity relationship. Curr Med Chem 23(5):498\u2013517","journal-title":"Curr Med Chem"},{"issue":"3","key":"10902_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2174\/157488607781668837","volume":"2","author":"H Nojima","year":"2007","unstructured":"Nojima H, Ohba Y, Kita Y (2007) Oleamide derivatives are prototypical anti-metastasis drugs that act by inhibiting connexin 26. Curr Drug Saf 2(3):204\u2013211","journal-title":"Curr Drug Saf"},{"issue":"1","key":"10902_CR17","doi-asserted-by":"publisher","first-page":"12598","DOI":"10.1038\/srep12598","volume":"5","author":"K Zibara","year":"2015","unstructured":"Zibara K, Awada Z, Dib L, El-Saghir J, Al-Ghadban S, Ibrik A et al (2015) Anti-angiogenesis therapy and gap junction Inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo. Sci Rep 5(1):12598","journal-title":"Sci Rep"},{"issue":"3","key":"10902_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1089\/bioe.2022.0010","volume":"4","author":"S Yerlikaya","year":"2022","unstructured":"Yerlikaya S, Djamgoz MBA (2022) Oleamide, a Sleep-Inducing compound: effects on ion channels and cancer. Bioelectricity 4(3):136\u2013144","journal-title":"Bioelectricity"},{"key":"10902_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s40478-023-01605-x","volume":"11","author":"F Ah-Pine","year":"2023","unstructured":"Ah-Pine F, Khettab M, Bedoui Y, Slama Y, Daniel M, Doray B et al (2023) On the origin and development of glioblastoma: multifaceted role of perivascular mesenchymal stromal cells. Acta Neuropathol Commun 11:104","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"10902_CR20","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.3390\/cancers15072116","volume":"15","author":"SSK Yalamarty","year":"2023","unstructured":"Yalamarty SSK, Filipczak N, Li X, Subhan MA, Parveen F, Ataide JA et al (2023) Mechanisms of resistance and current treatment options for glioblastoma multiforme (GBM). Cancers 15(7):2116","journal-title":"Cancers"},{"issue":"3","key":"10902_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrd3870","volume":"12","author":"DW McMillin","year":"2013","unstructured":"McMillin DW, Negri JM, Mitsiades CS (2013) The role of tumour-stromal interactions in modifying drug response: challenges and opportunities. Nat Rev Drug Discov 12(3):217\u2013228","journal-title":"Nat Rev Drug Discov"},{"issue":"16","key":"10902_CR22","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson NM, Simon MC (2020) Tumor microenvironment. Curr Biol 30(16):R921\u2013R925","journal-title":"Curr Biol"},{"issue":"4","key":"10902_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41577-019-0131-x","volume":"19","author":"G Altan-Bonnet","year":"2019","unstructured":"Altan-Bonnet G, Mukherjee R (2019) Cytokine-mediated communications: a quantitative appraisal of immune complexity. Nat Rev Immunol 19(4):205\u2013217","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10902_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41368-020-0086-6","volume":"12","author":"W Liu","year":"2020","unstructured":"Liu W, Cui Y, Wei J, Sun J, Zheng L, Xie J (2020) Gap junction-mediated cell-to-cell communication in oral development and oral diseases: a concise review of research progress. Int J Oral Sci 12(1):1\u20139","journal-title":"Int J Oral Sci"},{"issue":"2","key":"10902_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.expneurol.2010.07.014","volume":"225","author":"SSL Chew","year":"2010","unstructured":"Chew SSL, Johnson CS, Green CR, Danesh-Meyer HV (2010) Role of connexin43 in central nervous system injury. Exp Neurol 225(2):250\u2013261","journal-title":"Exp Neurol"},{"key":"10902_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2023.08.011","volume":"218","author":"X Xiong","year":"2024","unstructured":"Xiong X, Chen W, Chen C, Wu Q, He C (2024) Analysis of the function and therapeutic strategy of connexin 43 from its subcellular localization. Biochimie 218:1\u20137","journal-title":"Biochimie"},{"issue":"15","key":"10902_CR27","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.3390\/ijms21155216","volume":"21","author":"K Khosla","year":"2020","unstructured":"Khosla K, Naus CC, Sin WC (2020) Cx43 in neural progenitors promotes glioma invasion in a 3D culture system. Int J Mol Sci 21(15):5216","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10902_CR28","doi-asserted-by":"publisher","first-page":"e1145","DOI":"10.1038\/cddis.2014.111","volume":"5","author":"JL Munoz","year":"2014","unstructured":"Munoz JL, Rodriguez-Cruz V, Greco SJ, Ramkissoon SH, Ligon KL, Rameshwar P (2014) Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43. Cell Death Dis 5(3):e1145","journal-title":"Cell Death Dis"},{"issue":"4","key":"10902_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/or.2021.7995","volume":"45","author":"ZJ Yang","year":"2021","unstructured":"Yang ZJ, Zhang LL, Bi QC, Gan LJ, Wei MJ, Hong T et al (2021) Exosomal connexin 43 regulates the resistance of glioma cells to Temozolomide. Oncol Rep 45(4):1\u201310","journal-title":"Oncol Rep"},{"issue":"1","key":"10902_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1158\/0008-5472.CAN-15-1286","volume":"76","author":"SF Murphy","year":"2016","unstructured":"Murphy SF, Varghese RT, Lamouille S, Guo S, Pridham KJ, Kanabur P et al (2016) Connexin 43 Inhibition sensitizes chemoresistant glioblastoma cells to Temozolomide. Cancer Res 76(1):139\u2013149","journal-title":"Cancer Res"},{"key":"10902_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12967-014-0278-y","volume":"12","author":"N Yang","year":"2014","unstructured":"Yang N, Yan T, Zhu H, Liang X, Leiss L, Sakariassen P\u00d8 et al (2014) A co-culture model with brain tumor-specific bioluminescence demonstrates astrocyte-induced drug resistance in glioblastoma. J Transl Med 12:278","journal-title":"J Transl Med"},{"issue":"3","key":"10902_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s12032-015-0487-0","volume":"32","author":"W Chen","year":"2015","unstructured":"Chen W, Wang D, Du X, He Y, Chen S, Shao Q et al (2015) Glioma cells escaped from cytotoxicity of Temozolomide and vincristine by communicating with human astrocytes. Med Oncol 32(3):43","journal-title":"Med Oncol"},{"issue":"38","key":"10902_CR33","doi-asserted-by":"publisher","first-page":"62425","DOI":"10.18632\/oncotarget.11515","volume":"7","author":"W Chen","year":"2016","unstructured":"Chen W, Xia T, Wang D, Huang B, Zhao P, Wang J et al (2016) Human astrocytes secrete IL-6 to promote glioma migration and invasion through upregulation of cytomembrane MMP14. Oncotarget 7(38):62425\u201362438","journal-title":"Oncotarget"},{"issue":"23","key":"10902_CR34","doi-asserted-by":"publisher","first-page":"6017","DOI":"10.3390\/ijms20236017","volume":"20","author":"P Civita","year":"2019","unstructured":"Civita P, Leite M, Pilkington D (2019) Pre-Clinical drug testing in 2D and 3D human in vitro models of glioblastoma incorporating Non-Neoplastic astrocytes: tunneling nano tubules and mitochondrial transfer modulates cell behavior and therapeutic respons. Int J Mol Sci 20(23):6017","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10902_CR35","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/jcb.21018","volume":"100","author":"TH Chung","year":"2007","unstructured":"Chung TH, Wang SM, Chang YC, Chen YL, Wu JC (2007) 18beta-glycyrrhetinic acid promotes Src interaction with connexin43 in rat cardiomyocytes. J Cell Biochem 100(3):653\u2013664","journal-title":"J Cell Biochem"},{"issue":"19","key":"10902_CR36","doi-asserted-by":"publisher","first-page":"7019","DOI":"10.3390\/ijms21197019","volume":"21","author":"M Okada","year":"2020","unstructured":"Okada M, Fukuyama K, Shiroyama T, Murata M (2020) A working hypothesis regarding identical pathomechanisms between clinical efficacy and adverse reaction of clozapine via the activation of Connexin43. Int J Mol Sci 21(19):7019","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10902_CR37","doi-asserted-by":"publisher","first-page":"R248","DOI":"10.1152\/ajpregu.00268.2018","volume":"317","author":"X Hou","year":"2019","unstructured":"Hou X, Khan MRA, Turmaine M, Thrasivoulou C, Becker DL, Ahmed A (2019) Wnt signaling regulates cytosolic translocation of connexin 43. Am J Physiol Regul Integr Comp Physiol 317(2):R248\u2013R261","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"10902_CR38","doi-asserted-by":"publisher","first-page":"4722","DOI":"10.3390\/ijms24054722","volume":"24","author":"S Singh","year":"2023","unstructured":"Singh S, Gomez HJ, Thakkar S, Singh SP, Parihar AS (2023) Overcoming acquired drug resistance to cancer therapies through targeted STAT3 Inhibition. Int J Mol Sci 24(5):4722","journal-title":"Int J Mol Sci"},{"key":"10902_CR39","doi-asserted-by":"publisher","first-page":"1098482","DOI":"10.3389\/fcell.2023.1098482","volume":"11","author":"W Fu","year":"2023","unstructured":"Fu W, Hou X, Dong L, Hou W (2023) Roles of STAT3 in the pathogenesis and treatment of glioblastoma. Front Cell Dev Biol 11:1098482","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"10902_CR40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1158\/2159-8290.CD-19-0400","volume":"10","author":"P Chen","year":"2020","unstructured":"Chen P, Hsu WH, Chang A, Tan Z, Lan Z, Zhou A et al (2020) Circadian regulator CLOCK recruits immune suppressive microglia into the GBM tumor microenvironment. Cancer Discov 10(3):371\u2013381","journal-title":"Cancer Discov"},{"issue":"2","key":"10902_CR41","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3892\/ijo.2017.4059","volume":"51","author":"S Wang","year":"2017","unstructured":"Wang S, Shen Y, Qiu R, Chen Z, Chen Z, Chen W (2017) 18 \u03b2-glycyrrhetinic acid exhibits potent antitumor effects against colorectal cancer via Inhibition of cell proliferation and migration. Int J Oncol 51(2):615\u2013624","journal-title":"Int J Oncol"},{"key":"10902_CR42","first-page":"188","volume":"22","author":"MSB Mohamad","year":"2023","unstructured":"Mohamad MSB, Reyes RJ, De Rubis G, Paudel KR, Hansbro PM, Dua K et al (2023) The versatility of 18\u00df-glycyrrhetinic acid in attenuating pulmonary inflammatory disorders. EXCLI J 22:188\u2013190","journal-title":"EXCLI J"},{"key":"10902_CR43","doi-asserted-by":"publisher","unstructured":"West A, Tsui V, Stylli S, Nguyen H, Morokoff A, Kaye A et al (2018) The role of interleukin-6STAT3 signalling in glioblastoma (Review). Oncology Letters [Internet].; Available from: https:\/\/doi.org\/10.3892\/ol.2018.9227","DOI":"10.3892\/ol.2018.9227"},{"key":"10902_CR44","doi-asserted-by":"publisher","unstructured":"Yuan S, Yan Q, Zhao ZY, Zhang JL, Zhang H, Yin H et al (2022) STAT3-mediated upregulation of LINC00520 contributed to temozolomide chemoresistance in glioblastoma by interacting with RNA-binding protein LIN28B. Cancer Cell International.;22(1). Available from: https:\/\/doi.org\/10.1186\/s12935-022-02659-y","DOI":"10.1186\/s12935-022-02659-y"},{"key":"10902_CR45","unstructured":"Niu X, Zhang Y, Wang Y Co-culture models for investigating cellular crosstalk in the glioma microenvironment. Cancer Pathogenesis and Therapy [Internet]. 2023 Nov 7 [cited 2024 Jun 13]; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2949713223000915"},{"issue":"1","key":"10902_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1247\/csf.07011","volume":"33","author":"H Katayama","year":"2008","unstructured":"Katayama H, Yamamoto A, Mizushima N, Yoshimori T, Miyawaki A (2008) GFP-like proteins stably accumulate in lysosomes. Cell Struct Funct 33(1):1\u201312","journal-title":"Cell Struct Funct"}],"updated-by":[{"DOI":"10.1007\/s11033-025-11428-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000}}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10902-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10902-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10902-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:01:53Z","timestamp":1768032113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10902-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10902"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10902-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Figures 1B and 2A have been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11033-025-11428-9","URL":"https:\/\/doi.org\/10.1007\/s11033-025-11428-9","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on commercial cultured cell lines and does not contain any new studies with human participants or animals performed by any of the authors, it does not require the approval of the independent ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"803"}}